11/11/2024  17:26:22 Chg. +0.35 Volume Bid14/10/2024 Demandez à10/09/2024 Capitalisation boursière Dividende Y. Rapport P/E
76.48EUR +0.46% 272
Chiffrre d'affaires: 20,839
-Bid taille: - -Ask la taille: - 2.54 Mrd.EUR 1.64% 21.91

Description de l'entreprise

Gerresheimer is a leading global partner to the pharma and healthcare industry. With its specialty glass and plastic products, the company contributes to health and well-being. It has worldwide operations and about 10,000 employees manufacture the products in local markets, close to its customers. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
 

Conseil d'administration & Conseil de surveillance

PDG
Dietmar Siemssen
Conseil d'administration
Dr. Bernd Metzner, Dr. Lukas Burkhardt
Conseil de surveillance
Dr. Axel Herberg, Francesco Grioli, Andrea Abt, Dr. Karin Louise Dorrepaal, Dr. Peter Noé, Katja Schnitzler, Markus Rocholz, Paul Schilling, Udo J. Vetter, Prof. Dr. Annete G. Köhler, Marlis Mergenthal, Robert Fröhler
 

Données de l'entreprise

Nom: Gerresheimer AG
Adresse: Klaus-Bungert-Straße 4,D-40468 Düsseldorf
Téléphone: +49-211-6181-00
Fax: +49-211-6181-295
Courriel: info@gerresheimer.com
Internet: www.gerresheimer.com
Industrie: Healthcare
Secteur: Medical Products
Sous-secteur: Advanced Medical Devices
Fin de l'exercice financier: 30/11
Flotte libre: 43.29%
IPO date: 11/06/2007

Relations avec les investisseurs

Nom: Carolin Nadilo
Téléphone IR: +49-211-6181-314
IR-Fax: +49-211-6181-121
E-mail IR: carolin.nadilo@gerre...mer.com carolin.nadilo@gerresheimer.com